- Home
- AUGO vs INDV Comparison
AUGO vs INDV Comparison
Compare AUGO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUGO | INDV |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | United States |
| Employees | 1462 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.4B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | AUGO | INDV |
|---|---|---|
| Price | $54.81 | $40.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.60 | N/A |
| AVG Volume (30 Days) | 890.1K | ★ 1.6M |
| Earning Date | 05-06-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $91.05 | N/A |
| Revenue Next Year | $17.09 | N/A |
| P/E Ratio | ★ N/A | $58.71 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $23.55 | $16.69 |
| 52 Week High | $110.32 | $42.81 |
Technical Indicators
Market Signals| Indicator | AUGO | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 53.87 |
| Support Level | $48.35 | $39.20 |
| Resistance Level | $69.53 | $41.42 |
| Average True Range (ATR) | 3.51 | 1.37 |
| MACD | 0.14 | -0.15 |
| Stochastic Oscillator | 34.59 | 56.03 |
Price Performance
Historical ComparisonAbout AUGO Aura Minerals Inc.
Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).